Cronos Group Inc. Files 8-K on Officer/Director Changes

Ticker: CRON · Form: 8-K · Filed: 2025-03-19T00:00:00.000Z

Sentiment: neutral

Topics: governance, officer-changes, director-changes, filing

Related Tickers: CRON

TL;DR

CRON leadership shuffle and exec comp details filed. Check it.

AI Summary

Cronos Group Inc. filed an 8-K on March 19, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes financial statements and exhibits.

Why It Matters

This filing provides crucial updates on the company's leadership and governance structure, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: medium — Changes in directors and officers, especially if numerous or at high levels, can signal internal shifts or strategic realignments that may carry risks.

Key Players & Entities

Cronos Group Inc. (company) — Registrant
March 19, 2025 (date) — Date of earliest event reported

FAQ

What specific officer or director positions were affected by the changes reported in this 8-K?

The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' but does not specify names or exact positions within the provided text.

Are there any details about new compensatory arrangements for officers mentioned in the filing?

The filing lists 'Compensatory Arrangements of Certain Officers' as an item of disclosure, but the specific details of these arrangements are not included in the provided text.

What is the significance of the 'Financial Statements and Exhibits' being filed alongside the officer and director changes?

Filing financial statements and exhibits alongside governance changes suggests a comprehensive update to the company's public disclosures, potentially providing context for the leadership changes or reporting on recent financial performance.

When was the previous name change for Cronos Group Inc. (formerly PharmaCan Capital Corp.)?

The former company name, PharmaCan Capital Corp., was changed on October 21, 2015.

What is the primary business of Cronos Group Inc. according to the SIC code?

According to the Standard Industrial Classification (SIC) code 2833, Cronos Group Inc. is involved in 'MEDICINAL CHEMICALS & BOTANICAL PRODUCTS'.

From the Filing

0001656472-25-000047.txt : 20250319 0001656472-25-000047.hdr.sgml : 20250319 20250319073608 ACCESSION NUMBER: 0001656472-25-000047 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250319 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250319 DATE AS OF CHANGE: 20250319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 25750871 BUSINESS ADDRESS: STREET 1: 4491 CONCESSION RD 12 CITY: STAYNER STATE: A6 ZIP: L0M 1S0 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 6D - 7398 YONGE ST STREET 2: PMB 732 CITY: THORNHILL STATE: A6 ZIP: L4J 8J2 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 8-K 1 cron-20250319.htm 8-K cron-20250319 false 0001656472 0001656472 2024-08-08 2024-08-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 4491 Concession Rd 12 Stayner, Ontario L0M 1S0 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 416 ) 504-0004 N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, no par value CRON The NASDAQ Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective as of March 19, 2025 (the “Effective Date”), Cronos Group Inc. (the “Company”) has appointed Anna Shlimak, the Company’s Chief Strategy Officer, as the Company’s Chief Financial Officer. As of the Effective Date, James Holm will no longer serve as the Company’s Chief Financial Officer. Mr. Holm will continue to be employed by the Company and Cronos USA Client Services LLC